Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2014 Apr;20(4):299-300.
doi: 10.1111/cns.12245.

The epigenetics changes in Parkinson's disease: a novel therapeutic target

Ti-Fei Yuan  1 , Jiang Li, Chun-Lei Shan
Affiliations
Editorial

The epigenetics changes in Parkinson's disease: a novel therapeutic target

Ti-Fei Yuan et al. CNS Neurosci Ther. 2014 Apr.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Comment on

References

    1. Coppede F. Genetics and epigenetics of Parkinson's disease. ScientificWorldJournal 2012;2012:489830. - PMC - PubMed
    1. Outeiro TF, Kontopoulos E, Altmann SM, Kufareva I, Strathearn KE, Amore AM, et al. Sirtuin 2 inhibitors rescue alpha‐synuclein‐mediated toxicity in models of Parkinson's disease. Science 2007;317:516–519. - PubMed
    1. Du G, Liu X, Chen X, Song M, Yan Y, Jiao R, et al. Drosophila histone deacetylase 6 protects dopaminergic neurons against {alpha}‐synuclein toxicity by promoting inclusion formation. Mol Biol Cell 2010;21:2128–2137. - PMC - PubMed
    1. Zhu M, Li WW, Lu CZ. Histone decacetylase inhibitors prevent mitochondrial Fragmentation and elicit early neuroprotection against MPP+. CNS Neurosci Ther 2013;20:308–316. - PMC - PubMed
    1. Jowaed A, Schmitt I, Kaut O, Wullner U. Methylation regulates alpha‐synuclein expression and is decreased in Parkinson's disease patients' brains. J Neurosci 2010;30:6355–6359. - PMC - PubMed

MeSH terms

LinkOut - more resources